
IASLC/X
Jul 27, 2025, 15:57
A Deep Dive Into the Most Important Lung Cancer Trials Presented at ASCO25 – IASLC
The International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn:
“The newest episode of Lung Cancer Considered is part of the IASLC’s world-language podcast series and highlights key trial insights from a Japanese clinical perspective.
Dr. Misako Nagasaka is joined by Dr. Yasushi Goto and Dr. Yuko Oya for a deep dive into the most important lung cancer trials presented at ASCO25.
Featured studies include:
- CheckMate 816
- NEOADAURA
- TROPION-Lung02
- REZILIENT1
- DeLLphi-304
Listen here:”
More posts featuring IASLC.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 27, 2025, 15:38
Jul 27, 2025, 15:14
Jul 27, 2025, 15:03
Jul 27, 2025, 14:26
Jul 27, 2025, 14:04
Jul 27, 2025, 13:56
Jul 27, 2025, 13:48
Jul 27, 2025, 13:42